Purchase genuine medicines online as new ePharmacy draft moots single registry
Now, e-pharmacies would only have to seek one licence from the Drug Controller General of India, the country's apex drug regulator and central licencing authority. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 21, 2018 Category: Pharmaceuticals Source Type: news

Fosun targets Fortis: A white knight or a dark horse?
Often known as China's Warren Buffett, Guo Guangchang prefers to be his student instead. His mysterious disappearance last year raised many eyebrows. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 18, 2018 Category: Pharmaceuticals Source Type: news

AstraZeneca to invest $90 million in India over next 5 years
The announcement follows the signing of a bilateral innovation partnership for a sustainable future between Sweden and India. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 17, 2018 Category: Pharmaceuticals Source Type: news

Won ’t pursue irrational bid for Fortis: Manipal Hospitals CEO
Manipal, backed by private equity firm TPG, sweetened the offer price for Fortis Healthcare to Rs 155 apiece, up from Rs 130 announced barely a fortnight back. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 12, 2018 Category: Pharmaceuticals Source Type: news

Milan Paleja to head Novartis India's pharmaceuticals business
Paleja, previously president and head of pharmaceuticals for Novartis Indonesia, will also head Novartis India's pharmaceutical business, according to the firm. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 11, 2018 Category: Pharmaceuticals Source Type: news

Dr Reddy's gets EIR from USFDA for Cuernavaca plant in Mexico
The company had earlier said in a regulatory filing that audit of its active pharmaceutical ingredient (API) Cuernavaca plant in Mexico by the USFDA was completed with zero observations. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 10, 2018 Category: Pharmaceuticals Source Type: news

Roche looks to bring evidence-based medicine tech to India
Lara Bezerra, Roche Managing Director (India), who moved from the troubled Venezuela market to India, told ET that as part of its long-term strategy the company can bring applications of Flatiron. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 10, 2018 Category: Pharmaceuticals Source Type: news

Why government's new draft rule could make or break e-pharmacies like NetMeds, PharmEasy
Experts say e-pharmacies are here to stay, with their discounts and doorstep deliveries. Fair and just regulation is the need of the hour but the devil is in the details. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 10, 2018 Category: Pharmaceuticals Source Type: news

The story of Juneja siblings, the biggest disruptors in Indian pharma space
These former medical representatives have consistently struck gold at the bottom of the pyramid, selling drugs everywhere, priced lower than most others. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 9, 2018 Category: Pharmaceuticals Source Type: news

Alembic Pharma gets USFDA nod for Acyclovir ointment
The company has received approval from the USFDA for its abbreviated new drug application (ANDA) Acyclovir ointment USP, 5 per cent, Alembic Pharmaceuticals said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 9, 2018 Category: Pharmaceuticals Source Type: news

Health Ministry bans over-the-counter sale of 14 steroid creams
The ministry has put 14 steroid-based creams and ointments under the Schedule H category by making amendments to certain Drugs and Cosmetics Rules, 1945. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 8, 2018 Category: Pharmaceuticals Source Type: news

Rakesh Kumar Vats given additional charge of NPPA Chairman
He replaces Bhupendra Singh who was made chairperson of National Authority for Chemical Weapons Convention under the Cabinet Secretariat. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 7, 2018 Category: Pharmaceuticals Source Type: news

RK Vats to be new NPPA chairman
This will be an additional charge for Vats, an Indian Administrative Services official from the 1986 West Bengal cadre. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 6, 2018 Category: Pharmaceuticals Source Type: news

Lupin gets EIR from USFDA for Pithampur facility
In November last, Lupin had received warning letter from USFDA (US Food and Drug Administration) for its manufacturing facilities in Goa and Pithampur. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 6, 2018 Category: Pharmaceuticals Source Type: news

Glenmark recalls over 1 lakh bottles of anti-inflammatory drug in US
Glenmark Pharmaceuticals Inc USA is recalling 109,080 bottles of Indomethacin capsules USP, 50 mg, 100-count bottle, manufactured by Glenmark Pharmaceuticals at its Goa plant, USFDA said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 5, 2018 Category: Pharmaceuticals Source Type: news

US may revoke special tariff if India continues pricing control on medical devices
USTR representatives will be meeting Indian authorities on this issue with the message that India will lose the Generalised System of Preference if it continues pricing measures on medical devices. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 4, 2018 Category: Pharmaceuticals Source Type: news

Pharma may see recovery with FY19 profit set to jump 20-22%: Crisil
This will be primarily on the back of strong growth in the overseas market, particularly in the regulated markets of the US and the EU, it said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 3, 2018 Category: Pharmaceuticals Source Type: news

Prices of 869 formulations to go up by 3.44%: NPPA
The development follows a price revision as per annual Wholesale Price Index (WPI) at the rate of 3.44 percent increase, the National Pharmaceutical Pricing Authority (NPPA) said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 2, 2018 Category: Pharmaceuticals Source Type: news

ChrysCapital set to acquire 10% in Mankind for $350 million
Investment bank Moelis& Co has been running a keenly contested formal process that had also seen interest from Warburg Pincus, General Atlantic and Apax Partners. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 2, 2018 Category: Pharmaceuticals Source Type: news

Drug regulator plans national digital database of pharma manufacturers
CDSCO is finalising software and plans to amend rules for drugs and cosmetics to make it mandatory for manufacturers to regularly put facility and product details in this database. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 2, 2018 Category: Pharmaceuticals Source Type: news

Lupin's Pithampur unit gets Health Canada clearance
In November 2017, Lupin had received warning letter from US Food and Drug Administration for its manufacturing facilities in Goa and Pithampur, Indore. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 2, 2018 Category: Pharmaceuticals Source Type: news

At the helm at Dr. Reddy's, Erez Israeli will have his task cut out
Israeli will replace Abhijit Mukherjee, who retires following his 15-year stint at the company. Mukherjee's tenure as COO was marked with unexpected headwinds. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 2, 2018 Category: Pharmaceuticals Source Type: news

Strides Shasun gets USFDA nod for generic Ibuprofen capsules
The generic Ibuprofen capsules, 200 mg, is meant for relieving pain and will be manufactured at the company's oral dosage facility in Bangalore. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 2, 2018 Category: Pharmaceuticals Source Type: news

Tata Trusts and Google explore cancer care pact
On Wednesday Tata Trusts chairman Ratan Tata met Google co-founders Larry Page and Sergey Brin along with chief executive Sundar Pichai at their headquarters in California to discuss the future collaboration. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 30, 2018 Category: Pharmaceuticals Source Type: news

Dr Reddy's hires former Teva exec to lead the business
His knowledge and experience from leading pharmaceutical businesses of scale will be valuable for our future growth, ” said G.V. Prasad CEO Dr Reddys Laboratories. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 29, 2018 Category: Pharmaceuticals Source Type: news

Merck appoints Milind Thatte as MD
He heads the leadership team of healthcare sector and is the member of the country council of Merck India, it added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 27, 2018 Category: Pharmaceuticals Source Type: news

CDSCO's new intelligence cell to check illegal activity in India ’s pharma sector
This includes gathering information on the medicines and cosmetics imported or exported against the law and investigating complaints related to medicine quality received from overseas regulatory agencies, according to an office order dated March 26. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 27, 2018 Category: Pharmaceuticals Source Type: news

Growing drug resistance: Antibiotic consumption in India has skyrocketed, finds new study
Antibiotic consumption in India increased 103% between 2000 and 2015 —the highest in low and middle-income countries, according to the study. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 27, 2018 Category: Pharmaceuticals Source Type: news

Glenmark gets USFDA nod for psoriasis spray
Glenmark Pharmaceuticals Inc, USA has received final approval by the United States Food& Drug Administration (USFDA) for Clobetasol Propionate spray 0.05 per cent, the company said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 27, 2018 Category: Pharmaceuticals Source Type: news

Zydus Cadila gets USFDA nod for cardiac drug
The product will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad, Zydus Cadila said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 26, 2018 Category: Pharmaceuticals Source Type: news

Dr Reddy's launches generic nausea drug in US
The Hyderabad-based firm launched the product after getting approval from the US Food and Drug Administration, Dr Reddy's Labs said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 26, 2018 Category: Pharmaceuticals Source Type: news

Parliamentary panel recommends fixing of 'minimum compulsory period' of working within country for doctors
The Parliamentary panel has also asked the health ministry to explore "restructuring and revamping" of various councils for their effective regulation. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 25, 2018 Category: Pharmaceuticals Source Type: news

Pharma firms don't need NOC for exporting drugs, medical devices
Previously, licensed manufacturers of drugs and medical devices could export them only to the US, Canada, Japan, Australia and the European Union. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 23, 2018 Category: Pharmaceuticals Source Type: news

Daiichi Sankyo spreading falsehood: Fortis
ET reported on March 19 that Daiichi had written to ED seeking an investigation on allegations that the Singh brothers siphoned off money from Fortis Healthcare and Religare Enterprises. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 22, 2018 Category: Pharmaceuticals Source Type: news

Tildra approval to give sentimental push to Sun Pharma
​​The drug which will be sold under the brand name Ilumya is expected to treat adults for moderate to severe plaque psoriasis, an autoimmune disease. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 22, 2018 Category: Pharmaceuticals Source Type: news

Suven Life gets patents from Norway, South Korea, Singapore
The granted claims pertain to new chemical entities (NCEs) developed by the firm to treat disorders associated with neurodegenerative diseases. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 22, 2018 Category: Pharmaceuticals Source Type: news

Decoding the impact of the Ilumya, Sun Pharma's first biologic drug approved by the US FDA
Last year Sun Pharma signed another deal with South Korea's Samsung Biologics to get the drug manufactured on approval. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 22, 2018 Category: Pharmaceuticals Source Type: news

Modicare to be ready for launch by July end
An important aspect of the paperless, cashless and IT-based health insurance scheme is the validation of the target audience who can avail the benefit. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 22, 2018 Category: Pharmaceuticals Source Type: news

Sun Pharma gets USFDA nod for plaque psoriasis drug
The FDA approval of the drug was supported by data from the pivotal phase-3 resurface clinical development program, it said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 21, 2018 Category: Pharmaceuticals Source Type: news

New medical devices procurement guidelines propose to make 20-50% of components in India
DoP has prescribed the requirements based on its current understanding of the medical devices market in India, according to the draft. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 19, 2018 Category: Pharmaceuticals Source Type: news

Lupin gets USFDA nod for psoriasis treatment spray
Desoximetasone Topical spray, used for treatment of plaque psoriasis, has received approval from the US health regulator for sale in the American market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 19, 2018 Category: Pharmaceuticals Source Type: news

Orchid gets three final bids at par with liquidation value
The company had to sell assets to rein in debt. In 2012, it sold its penicillin business to US drug maker Hospira for $200 million. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 19, 2018 Category: Pharmaceuticals Source Type: news

Anti-dumping duty imposed on Ofloxacin import from China
The duty on import of 'Ofloxacin' from China will be in the range of $2.58 to $9.48 per kilogram for three years, said a notification issued by the revenue department in the finance ministry. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 18, 2018 Category: Pharmaceuticals Source Type: news

Your medicine box may have fake drugs
Raids by the crime branch have led to the seizure of more than 90,000 capsules and tablets of antacids and multivitamins commonly consumed in every household. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 18, 2018 Category: Pharmaceuticals Source Type: news

Tata Capital looking to exit Sai Life Sciences; Top PE funds in the race
Around 35% stake of the Hyderabad-based firm is being sold. General Atlantic, Warburg Pincus, Apax Partners and Temasek among interested bidders. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 17, 2018 Category: Pharmaceuticals Source Type: news

Zydus gets USFDA nod to market drugs for stomach ailments
"Zydus Cadila has received the final approval from USFDA to market Omeprazole and Sodium bicarbonate capsules 20 mg/1100 mg (OTC)," the company said in a filing to BSE. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 17, 2018 Category: Pharmaceuticals Source Type: news

Wockhardt under NPPA lens over essential blood pressure medicine price
The medicines in question are methyldopa 250 mg and methyldopa 500 mg and both of these are currently under price control. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 17, 2018 Category: Pharmaceuticals Source Type: news

CDSCO flags drug firms for making and selling combination medicines without approval
Over 70 fixed dose combination (FDC) medicine brands marketed by 16 pharma companies have been seized in an ongoing raid of two drug manufacturing facilities. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 17, 2018 Category: Pharmaceuticals Source Type: news

Dr Reddy's gets 4 observations from USFDA for Telangana plant
US health regulator has issued four observations after inspecting Dr Reddy's active pharmaceutical ingredients (API) facility in Telangana. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 16, 2018 Category: Pharmaceuticals Source Type: news

Dr Reddy's launches allergy relief tablets in US
Levocetirizine dihydrochloride tablets are used for 24-hour relief of allergy symptoms such as watery eyes, runny nose, itching eyes/nose and sneezing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 16, 2018 Category: Pharmaceuticals Source Type: news